(1 - 5 von 5
)
ETH Spinoff enters an agreement with Boehringer Ingelheim
www.startupticker.ch
... to identify compounds with superior biological properties for one of Boehringer's target receptors”, says Maria Waldhoer, CSO at InterAx.
Large Pharma Company Selects InterAx Biotech
www.startupticker.ch
... compounds with superior biological properties for their target receptor with our unique technology”, says Maria Waldhoer, CSO at InterAx.
Newsfeed – ONCOgenic GPCR Network of Excellence and Training
oncornet.eu
InterAx Biotech (Maria Waldhoer, CH). Other partner organizations are: Cisbio ( Eric Trinquet, FR), Sosei Heptares (Chris de Graaf, UK), ALMAC (Alastair Hay, ...
Of molecular dances, G proteins and friendship – Einstein Stiftung...
www.einsteinfoundation.de
Die Einstein Stiftung fördert Wissenschaft und Forschung in Berlin auf internationalem Spitzenniveau.
Startups join forces in the fight against cancer | S-GE
www.s-ge.com
Two biotech spin-offs of the Paul Scherrer Institute are joining forces to develop drug molecules targeting G-protein coupled receptors, which play a role in...
sortiert nach Relevanz / Datum